Mateusz Kaczmarek, Author at TechStock²

Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

As of mid-afternoon on November 17, 2025, Canadian Solar Inc. (CSIQ) is trading around $29–30 per share, after an extremely volatile few sessions that saw the stock spike to the mid‑$30s following its Q3 2025 earnings release. MarketBeat 1. Stock

17 November 2025

Company News·Financial Analysis·Investment Strategies·Renewable Energy·Stock Market

Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

On Monday, November 17, 2025, Clearwater Analytics Holdings, Inc. (NYSE: CWAN) once again jumped onto traders’ radar as renewed buyout speculation from private equity giants Warburg Pincus and Permira pushed the stock sharply higher in pre‑market trading and kept it

17 November 2025

Financial Updates·Investment Analysis·Mergers & Acquisitions·Stock Market News

E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

On November 17, 2025, Sinclair Inc. disclosed an 8.2% stake in The E.W. Scripps Company (NASDAQ: SSP) and confirmed it is pursuing a merger, sending SSP stock more than 20% higher. Here’s what the potential Sinclair–Scripps deal means for investors,

17 November 2025

Business Analysis·Company News·Media Industry·Mergers & Acquisitions·Stock Market

Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust, Inc. (NYSE: MPW) is back in the headlines today after announcing a 12% increase to its regular quarterly dividend, alongside updates that underscore its ongoing recovery story and capital-return strategy. On November 17, 2025, the healthcare REIT

17 November 2025

Dividend News·Financial Updates·Investment Strategies·Stock Market

Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics Inc. (NASDAQ: RPTX) is back in the spotlight today after investors digested last week’s surprise acquisition agreement with XenoTherapeutics, Inc., a Massachusetts-based non‑profit biotech. The stock is trading sharply higher and unusually active as the market prices in

17 November 2025

Biotech Industry·Financial Updates·Investment Analysis·Mergers & Acquisitions·Stock Market News

Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems Ltd. (NASDAQ: ESLT; TASE: ESLT) is back in the global spotlight today after announcing a massive $2.3 billion international defense contract, sending the stock sharply higher just one day before its third‑quarter 2025 earnings report. The deal, disclosed

17 November 2025

Defense Industry·Earnings Reports·Market News·Stocks

Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

Chilean lithium giant jumps ~12% on Monday as big funds buy in, lithium prices spike on China optimism, and investors brace for Q3 2025 earnings. Sociedad Química y Minera de Chile S.A. (NYSE: SQM) is back in the spotlight. By

17 November 2025

Business News·Lithium·Mining Industry·Stock Market

PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group (NYSE: PACS) jumps more than 40–50% after announcing plans to file all overdue SEC reports and release Q3 2025 earnings on November 19, easing delisting and default fears for the nursing-home giant. Shares of PACS Group, Inc. (NYSE:

17 November 2025

Company Updates·Financial News·Investing·Stock Market

ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) is back in the spotlight today, November 17, 2025, as the stock trades sharply higher while fresh institutional buying, surging options activity and a looming earnings release collide in a single, high‑volatility narrative.

17 November 2025

Earnings Reports·Financial Analysis·Investment News·Stock Market

Lucid Group (LCID) Stock Crashes to New All‑Time Low as Stifel Slashes Target and $875M Debt Deal Closes

Lucid Group, Inc. (NASDAQ: LCID) is under intense pressure today as its share price sinks to a new all‑time low, capping a brutal two‑week slide driven by weak earnings, fresh debt, analyst downgrades and ongoing concerns about cash burn at

17 November 2025

Electric Vehicles·Financial News·Investing·Stock Market

Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer Inc. (NYSE: PFE) is back in the headlines today with a flurry of developments that span new product launches, obesity-drug M&A, fresh vaccine data and ongoing debate about whether its battered stock is finally a buy. As of this

17 November 2025

Business Deals·Pharmaceuticals·Stock Market

GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

On Monday, November 17, 2025, GameStop (NYSE: GME) is back at the center of the market conversation as its share price hovers just above $20 while retail traders debate new lows, short‑squeeze odds, and the company’s latest viral promotion, “Trade

17 November 2025

Investing·Market Trends·Stock Market